Elevance Health(ELV) - 2024 Q1 - Quarterly Results

Exhibit 99.1 EARNINGS RELEASE ELEVANCE HEALTH REPORTS FIRST QUARTER 2024 RESULTS • 1Q 2024 operating revenue of $42.3 billion, up 0.9% from 1Q 2023 • 1Q 2024 diluted EPS1 of $9.59, up 15.5% from 1Q 2023 and adjusted diluted EPS2 of $10.64, up 12.5% • FY 2024 diluted EPS and adjusted diluted EPS guidance raised to greater than $34.05 and $37.20, respectively • Launching strategic partnership to advance primary care and physician enablement Indianapolis, IN—April 18, 2024—Elevance Health, Inc. (NYSE: ELV) rep ...